HARBOR CAPITAL ADVISORS, INC. Fate Therapeutics, Inc. Transaction History

HARBOR CAPITAL ADVISORS, INC. portfolio value:

$250,000
portfolio value

HARBOR CAPITAL ADVISORS, INC. quarter portfolio value change:

-9.56%
quarter

Fate Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -2.67% -306 shares -34K $22.41 11.14K
Q2 2022 share Decrease -9.88% -1.25K shares -209K $24.78 11.45K
Q1 2022 share Decrease -12.82% -1.86K shares -360K $38.77 12.70K
Q4 2021 share Increase 0.00% 14.57K shares 853K $60.07 14.57K